Advanced Transplant Diagnostics And Immunogenetics Private Limited - Company Profile

It is a healthcare private limited company based in Chakala, Andheri E Mumbai, Maharashtra, India, established in 2019.
2019 Chakala, Andheri E Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Advanced Transplant Diagnostics And Immunogenetics Private Limited

Advanced Transplant Diagnostics And Immunogenetics Private Limited, a active private limited company, was established on 09 September 2019 in Chakala, Andheri E Mumbai, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U93090MH2019PTC330328. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Bharat Vallabhdas Shah (Director), Shruti Niranjan Tapiawala (Director), Hepal Mihir Vora (Director). Past directors included Hepal Mihir Vora, Zaheer Aminmohamed Virani, Prashant Jayendrasingh Rajput. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 401, Rajveer Royals, Next To Jyoti Dwelling Bld, Ghatkopar Andheri Link Rd, Chakala, Andheri E Mumbai, Maharashtra, 400093.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U93090MH2019PTC330328

  • Registration Number

    330328

  • Incorporation Date

    09 September 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 63.83%
  • Profit Growth **** -35.08%
  • Ebitda **** -37.37%
  • Net Worth 58.27%
  • Total Assets **** 150.54%
Company report

Advanced Transplant Diagnostics And Immunogenetics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Advanced Transplant Diagnostics And Immunogenetics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Advanced Transplant Diagnostics And Immunogenetics Private Limited?
Current Directors
Name Designation Appointment Date Status
Bharat Vallabhdas Shah Director 09 Sep 2019 Current
Shruti Niranjan Tapiawala Director 09 Sep 2019 Current
Hepal Mihir Vora Director 06 Nov 2020 Current
Zaheer Aminmohamed Virani Director 06 Nov 2020 Current
Prashant Jayendrasingh Rajput Director 06 Nov 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 16 Aug 2022 Past
Pramod Abcsdd Additional Director 16 Aug 2022 Past
Pramod Abcsdd Additional Director 16 Aug 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Advanced Transplant Diagnostics And Immunogenetics.

Advanced Transplant Diagnostics And Immunogenetics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.83% increase. The company also saw a substantial fall in profitability, with a 35.08% decrease in profit. The company's net worth Soared by an impressive increase of 58.27%.

Advanced Transplant Diagnostics And Immunogenetics revenue growth over time
Advanced Transplant Diagnostics And Immunogenetics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 63.83%
*******
*******
*******
*******
Revenue from Operations
*******
 63.69%
*******
*******
*******
*******
Total Assets
*******
 150.54%
*******
*******
*******
*******
Profit or Loss
*******
 -35.08%
*******
*******
*******
*******
Net Worth
*******
 58.27%
*******
*******
*******
*******
EBITDA
*******
 -37.37%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Advanced Transplant Diagnostics And Immunogenetics?

In 2023, Advanced Transplant Diagnostics And Immunogenetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Advanced Transplant Diagnostics And Immunogenetics?

Unlock and access historical data on people associated with Advanced Transplant Diagnostics And Immunogenetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Advanced Transplant Diagnostics And Immunogenetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Transplant Diagnostics And Immunogenetics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Advanced Transplant Diagnostics And Immunogenetics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Advanced Transplant Diagnostics And Immunogenetics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Advanced Transplant Diagnostics And Immunogenetics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was recorded as a recent event.

  • Director Appointment

    Progress on Hepal Mihir Vora was appointed as a Director was appointed as a Director on 06 Nov 2020 & has been associated with this company since 5 years 4 months . was documented.

  • Director Appointment

    The activity Zaheer Aminmohamed Virani was appointed as a Director was appointed as a Director on 06 Nov 2020 & has been associated with this company since 5 years 4 months . was completed.

  • Director Appointment

    Progress on Prashant Jayendrasingh Rajput was appointed as a Director was appointed as a Director on 06 Nov 2020 & has been associated with this company since 5 years 4 months . was documented.

  • Director Appointment

    Bharat Vallabhdas Shah was appointed as a Director was appointed as a Director on 09 Sep 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Advanced Transplant Diagnostics And Immunogenetics Private Limited?

The CIN of Advanced Transplant Diagnostics And Immunogenetics Private Limited is U93090MH2019PTC330328.

Where is Advanced Transplant Diagnostics And Immunogenetics Private Limited headquartered?

Advanced Transplant Diagnostics And Immunogenetics Private Limited is headquartered at 401, Rajveer Royals, Next To Jyoti Dwelling Bld, Ghatkopar Andheri Link Rd, Chakala, Andheri E Mumbai, Maharashtra, 400093.

When was Advanced Transplant Diagnostics And Immunogenetics Private Limited incorporated?

Advanced Transplant Diagnostics And Immunogenetics Private Limited was incorporated on 09 September 2019.

Who are the current directors of Advanced Transplant Diagnostics And Immunogenetics Private Limited?

The current directors of Advanced Transplant Diagnostics And Immunogenetics Private Limited are

What is the primary industry of Advanced Transplant Diagnostics And Immunogenetics Private Limited?

The primary industry of Advanced Transplant Diagnostics And Immunogenetics Private Limited is Hospital And Medical Care.

Is Advanced Transplant Diagnostics And Immunogenetics Private Limited a listed company?

Advanced Transplant Diagnostics And Immunogenetics Private Limited is unlisted.

What is the capital structure of Advanced Transplant Diagnostics And Immunogenetics Private Limited?

The authorized capital of Advanced Transplant Diagnostics And Immunogenetics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available